IL160722A0 - Aryloxypropylamines as chemosensitizing agents in the treatment of cancer - Google Patents

Aryloxypropylamines as chemosensitizing agents in the treatment of cancer

Info

Publication number
IL160722A0
IL160722A0 IL16072202A IL16072202A IL160722A0 IL 160722 A0 IL160722 A0 IL 160722A0 IL 16072202 A IL16072202 A IL 16072202A IL 16072202 A IL16072202 A IL 16072202A IL 160722 A0 IL160722 A0 IL 160722A0
Authority
IL
Israel
Prior art keywords
aryloxypropylamines
cancer
treatment
chemosensitizing agents
chemosensitizing
Prior art date
Application number
IL16072202A
Other languages
English (en)
Original Assignee
Univ Ramot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ramot filed Critical Univ Ramot
Publication of IL160722A0 publication Critical patent/IL160722A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL16072202A 2001-09-10 2002-09-10 Aryloxypropylamines as chemosensitizing agents in the treatment of cancer IL160722A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/948,621 US6630454B2 (en) 2001-09-10 2001-09-10 Method and pharmaceutical composition for the treatment of cancer
PCT/IL2002/000750 WO2003022258A1 (fr) 2001-09-10 2002-09-10 Aryloxypropylamines utilisees en tant qu'agent chimiosensibilisateur dans le traitement du cancer

Publications (1)

Publication Number Publication Date
IL160722A0 true IL160722A0 (en) 2004-08-31

Family

ID=25488062

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16072202A IL160722A0 (en) 2001-09-10 2002-09-10 Aryloxypropylamines as chemosensitizing agents in the treatment of cancer

Country Status (7)

Country Link
US (3) US6630454B2 (fr)
EP (1) EP1425002A1 (fr)
JP (1) JP2005505559A (fr)
KR (1) KR20050026903A (fr)
CA (1) CA2460022A1 (fr)
IL (1) IL160722A0 (fr)
WO (1) WO2003022258A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994006422A1 (fr) * 1992-09-22 1994-03-31 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Utilisation de taxol pour traiter des lymphomes et des cancers du sein
US8050964B2 (en) * 1999-05-06 2011-11-01 Etagz, Inc. Computer-readable medium product label apparatus and method
US6630454B2 (en) * 2001-09-10 2003-10-07 Ramot At Tel-Aviv University Ltd. Method and pharmaceutical composition for the treatment of cancer
CN1281210C (zh) * 2003-11-29 2006-10-25 胡汛 五味子乙素在制备治疗肿瘤药物中的应用
US20060024722A1 (en) * 2004-07-30 2006-02-02 Mark Fischer-Colbrie Samples for detection of oncofetal fibronectin and uses thereof
WO2006078774A2 (fr) * 2005-01-19 2006-07-27 The Trustees Of The University Of Pennsylvania Regulation de l'autophagie et de la survie cellulaire
WO2008081477A1 (fr) * 2007-01-04 2008-07-10 Natco Pharma Limited Propanamines à 3-substitution 3-aryloxy
WO2021236498A1 (fr) * 2020-05-18 2021-11-25 Yale University Traitement de cancers à variant kras avec des inhibiteurs d'absorption de la sérotonine

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
US4018895A (en) 1974-01-10 1977-04-19 Eli Lilly And Company Aryloxyphenylpropylamines in treating depression
US4318477A (en) * 1980-09-22 1982-03-09 Kerpe Stase Z Pharmaceutical package
DE3587465T2 (de) * 1984-09-10 1994-01-20 Hsc Res Dev Corp Vielfache Drogen-Resistenz in Säugetierzellinien und Isolierung der determinanten Glykoprotein-DNS.
US5194428A (en) 1986-05-23 1993-03-16 Worcester Foundation For Experimental Biology Inhibition of influenza virus replication by oligonucleotide phosphorothioates
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
US5110802A (en) 1987-07-14 1992-05-05 City Of Hope Oligonucleotide phosphonates and method of inhibiting a human immunodeficiency virus in vitro utilizing said oligonucleotide phosphonates
US5216141A (en) 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
US5166437A (en) 1989-03-03 1992-11-24 Orion-Yhtyma Oy Process for the preparation of fluoxetine
JP2706371B2 (ja) * 1990-12-17 1998-01-28 ユニヴァーシティー オブ マニトバ 癌治療用補助剤及びそれを用いたキット
US5798339A (en) 1990-12-17 1998-08-25 University Of Manitoba Treatment method for cancer
GB9303210D0 (en) * 1993-02-17 1993-03-31 Univ Manitoba Cancer treatment
US5639950A (en) * 1992-09-29 1997-06-17 The Ohio State University Research Foundation Nucleotide sequence encoding for bifunctional enzyme for proline production
IL115582A0 (en) * 1994-10-14 1996-01-19 Lilly Co Eli Methods for treating resistant tumors
US5776925A (en) 1996-01-25 1998-07-07 Pharmacyclics, Inc. Methods for cancer chemosensitization
US5795895A (en) * 1997-06-13 1998-08-18 Anchors; J. Michael Combination anorexiant drug therapy for obesity using phentermine and an SSRI drug
EP1048659A4 (fr) 1997-11-12 2002-11-20 Inst Med Molecular Design Inc Agonistes du recepteur du retinoide
US20010041706A1 (en) * 2000-03-24 2001-11-15 Synold Timothy W. Blockade of taxane metabolism
US6927223B1 (en) * 2000-05-26 2005-08-09 Washington State University Research Foundation Use of serotonin agents for adjunct therapy in the treatment of cancer
IL139975A0 (en) * 2000-11-29 2002-02-10 Univ Ramot Anti proliferative drugs
US6258853B1 (en) 2001-01-31 2001-07-10 Grayson Walker Stowell Form a of fluoxetine hydrochloride
US6630454B2 (en) * 2001-09-10 2003-10-07 Ramot At Tel-Aviv University Ltd. Method and pharmaceutical composition for the treatment of cancer

Also Published As

Publication number Publication date
CA2460022A1 (fr) 2003-03-20
KR20050026903A (ko) 2005-03-16
WO2003022258A1 (fr) 2003-03-20
US20040266882A1 (en) 2004-12-30
US20030087964A1 (en) 2003-05-08
JP2005505559A (ja) 2005-02-24
EP1425002A1 (fr) 2004-06-09
US20040054014A1 (en) 2004-03-18
US6630454B2 (en) 2003-10-07

Similar Documents

Publication Publication Date Title
IL251270A0 (en) Cancer treatment
PL370029A1 (en) 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
AU6147401A (en) Compositions and methods for the treatment of cancer
AU2003213144A1 (en) Alkylating agent combinations in the treatment of cancer
HK1086488A1 (en) Compound and use thereof for the treatment of cancer
AU6048201A (en) Quinazoline derivatives for the treatment of tumours
GB0112343D0 (en) Well treatment
HK1072443A1 (en) Immunoconjugates for the treatment of tumours
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
AU2003212634A8 (en) Compounds useful in the treatment of cancer
PL368458A1 (en) Improved use of antitumoral compound in cancer therapy
HUP0500424A3 (en) Combination therapy for the treatment of cancer
HUP0400609A3 (en) Wet-skin treatment compositions
MXPA03008582A (es) Agentes y metodos para tratamiento de cancer.
HUP0300339A3 (en) Use of fulvestrant in the treatment of resistant breast cancer
PL368035A1 (en) Compositions and methods for the treatment of cancer
IL160722A0 (en) Aryloxypropylamines as chemosensitizing agents in the treatment of cancer
GB0026015D0 (en) Cancer treatment
EP1684795A4 (fr) Procedes et agents pour le traitement du cancer
GB0119370D0 (en) Therapeutic agent
EP1463511A4 (fr) Therapie anticancereuse combinatoire
AU2003247094A8 (en) Enhancing the effect of radioimmunotherapy in the treatment of tumors
GB0105244D0 (en) Cancer treatment methods and compositions
AU2002357468A1 (en) Use of 2-acylindoles in the treatment of tumors
GB0130694D0 (en) Treatment